Oxidative Stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Wojciechowska, Celina ^a   Romuk, Ewa ^a   Tomasik, Andrzej ^a   Skrzep Poloczek, Bronisława ^a   Nowalany Kozielska, Ewa ^a   Birkner, Ewa ^a   Jacheć, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; URIC ACID; BIOLOGICAL MARKER; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; BLOOD OXYGEN TENSION; CARDIOPULMONARY HEMODYNAMICS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; INFLAMMATION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEW YORK HEART ASSOCIATION CLASS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PULMONARY ARTERY OCCLUSION PRESSURE; URIC ACID BLOOD LEVEL; ADOLESCENT; BLOOD; CASE CONTROL STUDY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEMODYNAMICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY WEDGE PRESSURE; STROKE VOLUME; SUPEROXIDE DISMUTASE; URIC ACID; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84910617813     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/147040     Document Type: Article

References (45)

1. The Criteria Committee of the New York Heart Association, Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Blood Vessels 1964 Boston, Mass, USA Little Brown
2. Solomonica A., Burger A. J., Aronson D., Hemodynamic determinants of dyspnea improvement in acute decompensated heart failure. Circulation: Heart Failure 2013 6 1 53 60 10.1161/CIRCHEARTFAILURE.112.970335 2-s2.0-84873618109
3. McParland C., Krishnan B., Wang Y., Gallagher C. G., Inspiratory muscle weakness and dyspnea in chronic heart failure. The American Review of Respiratory Disease 1992 146 2 467 472 10.1164/ajrccm/146.2.467 2-s2.0-0026651439
4. Wilson J. R., Fink L., Maris J., Ferraro N., Power-Vanwart J., Eleff S., Chance B., Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 1985 71 1 57 62 10.1161/01.CIR.71.1.57 2-s2.0-0021916108
5. Jarreta D., Orús J., Barrientos A., Miró O., Roig E., Heras M., Moraes C. T., Cardellach F., Casademont J., Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovascular Research 2000 45 4 860 865 10.1016/S0008-6363(99)00388-0 2-s2.0-0342445429
6. Galiè N., Hoeper M. M., Humbert M., ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). European Heart Journal 2009 30 20 2493 2537 10.1093/eurheartj/ehp297
7. Knebel F., Schimke I., Pliet K., Schattke S., Martin S., Borges A. C., Baumann G., NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation. Journal of Cardiac Failure 2005 11 5 supplement 5 S38 S41 10.1016/j.cardfail.2005.04.012 2-s2.0-33644876940
8. Kindo M., Gerelli S., Bouitbir J., Charles A.-L., Zoll J., Minh T. H., Monassier L., Favret F., Piquard F., Geny B., Pressure overload-induced mild cardiac hypertrophy reduces left ventricular transmural differences in mitochondrial respiratory chain activity and increases oxidative stress. Frontiers in Physiology 2012 28 3, article 332 10.3389/fphys.2012.00332 2-s2.0-84866479334
9. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B. A., Griendling K. K., Harrison D. G., Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Journal of Clinical Investigation 1996 97 8 1916 1923 10.1172/JCI118623 2-s2.0-0030005713
10. Singal P. K., Beamish R. E., Dhalla N. S., Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Advances in Experimental Medicine and Biology 1983 161 391 401 10.1007/978-1-4684-4472-8-22 2-s2.0-0020668901
11. Oyama J.-I., Shimokawa H., Momii H., Cheng X.-S., Fukuyama N., Arai Y., Egashira K., Nakazawa H., Takeshita A., Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. Journal of Clinical Investigation 1998 101 10 2207 2214 10.1172/JCI986 2-s2.0-0032523838
12. Habib F. M., Springall D. R., Davies G. J., Oakley C. M., Yacoub M. H., Polak J. M., Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. The Lancet 1996 347 9009 1151 1155 10.1016/S0140-6736(96)90610-8 2-s2.0-0030603619
13. Sam F., Kerstetter D. L., Pimental D. R., Mulukutla S., Tabaee A., Bristow M. R., Colucci W. S., Sawyer D. B., Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. Journal of Cardiac Failure 2005 11 6 473 480 10.1016/j.cardfail.2005.01.007 2-s2.0-33644585112
14. Díaz-Vélez C. R., García-Castiñeiras S., Mendoza-Ramos E., Hernández-López E., Increased malondialdehyde in peripheral blood of patients with congestive heart failure. The American Heart Journal 1996 131 1 146 152 10.1016/S0002-8703(96)90063-0 2-s2.0-0030069613
15. Levine B., Kalman J., Mayer L., Fillit H. M., Packer M., Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. The New England Journal of Medicine 1990 323 4 236 241 10.1056/NEJM199007263230405 2-s2.0-0025286817
16. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J. B., Mann D. L., Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). Journal of the American College of Cardiology 1996 27 5 1201 1206 10.1016/0735-1097(95)00589-7 2-s2.0-0029871896
17. Voigt A., Rahnefeld A., Kloetzel P. M., Krüger E., Cytokine-induced oxidative stress in cardiac inflammation and heart failure-how the ubiquitin proteasome system targets this vicious cycle. Frontiers in Physiology 2013 4, article 42 10.3389/fphys.2013.00042 2-s2.0-84879492973
18. Consoli C., Gatta L., Iellamo F., Molinari F., Rosano G. M., Marlier L. N., Severity of left ventricular dysfunction in heart failure patients affects the degree of serum-induced cardiomyocyte apoptosis. Importance of inflammatory response and metabolism. International Journal of Cardiology 2013 167 6 2859 2866 10.1016/j.ijcard.2012.07.025 2-s2.0-84883799281
19. Vitiello D., Harel F., Touyz R. M., Sirois M. G., Lavoie J., Myers J., Ducharme A., Racine N., O'Meara E., Gayda M., Chabot-Blanchet M., Rouleau J. L., de Denus S., White M., Changes in cardiopulmonary reserve and peripheral arterial function concomitantly with sup>clinical inflammation and oxidative stress in patients with heart failure with preserved ejection fraction. International Journal of Vascular Medicine 2014 2014 8 917271 10.1155/2014/917271 2-s2.0-84897851118
20. Schimke I., Schikora M., Meyer R., Dübel H.-P., Modersohn D., Kleber F. X., Baumann G., Oxidative stress in the human heart is associated with changes in the antioxidative defense as shown after heart transplantation. Molecular and Cellular Biochemistry 2000 204 1-2 89 96 10.1023/A:1007030322514 2-s2.0-0033993796
21. Richardson P., McKenna R. W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., Nordet P., Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996 93 5 841 842 10.1161/01.CIR.93.5.841 2-s2.0-0029864693
22. Oyanagui Y., Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Analytical Biochemistry 1984 142 2 290 296 10.1016/0003-2697(84)90467-6 2-s2.0-0021722482
23. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 10.1016/0003-2697(79)90738-3 2-s2.0-0018384650
24. White M., Ducharme A., Ibrahim R., Whittom L., Lavoie J., Guertin M.-C., Racine N., He Y., Yao G., Rouleau J. L., Schiffrin E. L., Touyz R. M., Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clinical Science 2006 110 4 483 489 10.1042/CS20050317 2-s2.0-33645562485
25. Kukin M. L., Kalman J., Charney R. H., Levy D. K., Buchholz-Varley C., Ocampo O. N., Eng C., Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation 1999 99 20 2645 2651 10.1161/01.CIR.99.20.2645 2-s2.0-0033602801
26. Hornig B., Landmesser U., Kohler C., Ahlersmann D., Spiekermann S., Christoph A., Tatge H., Drexler H., Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 2001 103 6 799 805 10.1161/01.CIR.103.6.799 2-s2.0-0035852775
27. McMurray J., McLay J., Chopra M., Bridges A., Belch J. J. F., Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. The American Journal of Cardiology 1990 65 18 1261 1262 10.1016/0002-9149(90)90985-A 2-s2.0-0025307914
28. Diaz-Velez C. R., Garcia-Castineiras S., Mendoza-Ramos E., Hernandez-Lopez E., Increased malondialdehyde in peripheral blood of patients with congestive heart failure. The American Heart Journal 1996 31 1352 1356
29. Keith M., Geranmayegan A., Sole M. J., Kurian R., Robinson A., Omran A. S., Jeejeebhoy K. N., Increased oxidative stress in patients with congestive heart failure. Journal of the American College of Cardiology 1998 31 6 1352 1356 10.1016/S0735-1097(98)00101-6 2-s2.0-0032080550
30. 2 in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998 97 16 1536 1539 10.1161/01.CIR.97.16.1536 2-s2.0-0032574631
31. McMurray J., Chopra M., Abdullah I., Smith W. E., Dargie H. J., Evidence of oxidative stress in chronic heart failure in humans. European Heart Journal 1993 14 11 1493 1498 10.1093/eurheartj/14.11.1493 2-s2.0-0027767687
32. Borghi C., Cosentino E. R., Rinaldi E. R., Cicero A. F. G., Uricaemia and ejection fraction in elderly heart failure outpatients. European Journal of Clinical Investigation 2014 44 6 573 577 10.1111/eci.12273 2-s2.0-84900802909
33. Leyva F., Anker S., Swan J. W., Godsland I. F., Wingrove C. S., Chua T.-P., Stevenson J. C., Coats A. J. S., Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. European Heart Journal 1997 18 5 858 865 10.1093/oxfordjournals.eurheartj.a015352 2-s2.0-0030927319
34. Drager L. F., Lopes H. F., Maki-Nunes C., Trombetta I. C., Toschi-Dias E., Alves M. J. N. N., Fraga R. F., Jun J. C., Negrão C. E., Krieger E. M., Polotsky V. Y., Lorenzi-Filho G., The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS ONE 2010 5 8 e12065 10.1371/journal.pone.0012065 2-s2.0-77957795764
35. Bartziokas K., Papaioannou A. I., Loukides S., Papadopoulos A., Haniotou A., Papiris S., Kostikas K., Serum uric acid as a predictor of mortality and future exacerbations of COPD. European Respiratory Journal 2014 43 1 43 53 10.1183/09031936.00209212 2-s2.0-84891909387
36. Lavie L., Hefetz A., Luboshitzky R., Lavie P., Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. Journal of Molecular Neuroscience 2003 21 1 57 63 10.1385/JMN:21:1:57 2-s2.0-0141450467
37. Anker S. D., Doehner W., Rauchhaus M., Sharma R., Francis D., Knosalla C., Davos C. H., Cicoira M., Shamim W., Kemp M., Segal R., Osterziel K. J., Leyva F., Hetzer R., Ponikowski P., Coats A. J. S., Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003 107 15 1991 1997 10.1161/01.CIR.0000065637.10517.A0 2-s2.0-0037461111
38. Hill M. F., Singal P. K., Right and left myocardial antioxidant responses during heart failure sup>sequent to myocardial infarction. Circulation 1997 96 7 2414 2420 10.1161/01.CIR.96.7.2414 2-s2.0-0030754792
39. Tsutsui H., Ide T., Hayashidani S., Kinugawa S., Suematsu N., Utsumi H., Takeshita A., Effects of ACE inhibition on left ventricular failure and oxidative stress in dahl salt-sensitive rats. Journal of Cardiovascular Pharmacology 2001 37 6 725 733 10.1097/00005344-200106000-00010 2-s2.0-0034997368
40. Wagner K.-D., Gmehling G., Günther J., Stauss H. M., Mydlak K., Theres H., Scholz H., Schimke I., Contractile function of rat myocardium is less susceptible to hypoxia/reoxygenation after acute infarction. Molecular and Cellular Biochemistry 2001 228 1-2 49 55 10.1023/A:1013316525785 2-s2.0-0035706149
41. Wagner K.-D., Gmehling G., Günther J., Theres H., Mydlak K., Schimke I., Scholz H., Time-dependent changes of the susceptibility of cardiac contractile function to hypoxia-reoxygenation after myocardial infarction in rats. Molecular and Cellular Biochemistry 2002 241 1-2 125 133 10.1023/A:1020841126171 2-s2.0-0036891736
42. Singh N., Dhalla A. K., Seneviratne C., Singal P. K., Oxidative stress and heart failure. Molecular and Cellular Biochemistry 1995 147 1-2 77 81 10.1007/BF00944786 2-s2.0-0029049713
43. >2> a necessary evil for cell signaling. Science 2006 312 5782 1882 1883 10.1126/science.1130481 2-s2.0-33745631769
44. Rankinen T., Hietanen E., Väisänen S., Relationship between lipid peroxidation and plasma fibrinogen in middle-aged men. Thrombosis Research 2000 99 5 453 459 10.1016/S0049-3848(00)00271-1 2-s2.0-0034283317
45. Alonso-Martínez J. L., Llorente-Diez B., Echegaray-Agara M., Olaz-Preciado F., Urbieta-Echezarreta M., González-Arencibia C., C-reactive protein as a predictor of improvement and readmission in heart failure. European Journal of Heart Failure 2002 4 3 331 336 10.1016/S1388-9842(02)00021-1 2-s2.0-0036623813